General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

D’Cruze H et al. - Inclusion criteria were randomised placebo controlled trials in patients with a common cold. Five studies were found. Three were relevant to the issue of treatment of common colds with intranasal zinc and the results were combined in meta-analysis. High doses of intranasal zinc preparation (2.1mg zinc/day) were reported in two studies to shorten the duration and reduce the symptom severity of common cold in healthy adults, when started within 24 to 48 hours of onset of illness. A lower dose study (0.044mg zinc/day) found no benefit in resolution, but did report a significant improvement in symptoms at day 1 and day 3. Combining the three studies, the relative risk for benefit at day 3 was 0.62. There were no studies with children. There were no significant harms reported. Results from individual trials suggest some benefit from zinc for symptoms of a common cold, at least in adults. Pooling the results for symptom relief at day 3, in a conservative meta-analysis, suggests a non-significant benefit. Unquantified concerns about permanent anosmia following the use of intranasal zinc may mean that the issues raised will never be scientifically resolved.

Related Articles

Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/16/09    Relevance Score: 47%

Effects of Zinc Supplementation on Serum Zinc and C-Reactive Protein Concentrations in Hemodialysis Patients
Journal of Renal Nutrition, 10/13/09    Relevance Score: 45%

Zinc
The Clinical Advisor, 10/07/09    Relevance Score: 45%

Zinc: role in immunity, oxidative stress and chronic inflammation
Current Opinion in Clinical Nutrition & Metabolic Care, 10/21/09    Relevance Score: 44%

Super PoliGrip Now Contains Zinc Warning
Internet Source, 10/22/09    Relevance Score: 43%

Today in Clinical Pharmacology...keeping you current

Platelet Inhibition with Cangrelor in Patients Undergoing PCI
New England Journal of Medicine, 12/09/09

Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma
Liver International, 12/09/09

Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection
Journal of Gastroenterology, 12/09/09

Today in General Medicine...keeping you current

Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Clinic
COPD: Journal of Chronic Obstructive Pulmonary Disease, 12/09/09

Prevalence of Wet-to-Dry Dressings in Wound Care
Advances in Skin & Wound Care: The Journal for Prevention and Healing, 12/07/09

Acute pancreatitis: Problems in adherence to guidelines
Cleveland Clinic Journal of Medicine, 12/02/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address